1. Home
  2. SUPN vs ACMR Comparison

SUPN vs ACMR Comparison

Compare SUPN & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • ACMR
  • Stock Information
  • Founded
  • SUPN 2005
  • ACMR 1998
  • Country
  • SUPN United States
  • ACMR United States
  • Employees
  • SUPN N/A
  • ACMR N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • ACMR Industrial Machinery/Components
  • Sector
  • SUPN Health Care
  • ACMR Technology
  • Exchange
  • SUPN Nasdaq
  • ACMR Nasdaq
  • Market Cap
  • SUPN 1.7B
  • ACMR 1.6B
  • IPO Year
  • SUPN 2012
  • ACMR 2017
  • Fundamental
  • Price
  • SUPN $30.76
  • ACMR $19.36
  • Analyst Decision
  • SUPN Hold
  • ACMR Buy
  • Analyst Count
  • SUPN 2
  • ACMR 5
  • Target Price
  • SUPN $36.00
  • ACMR $30.50
  • AVG Volume (30 Days)
  • SUPN 647.0K
  • ACMR 1.9M
  • Earning Date
  • SUPN 05-07-2025
  • ACMR 05-08-2025
  • Dividend Yield
  • SUPN N/A
  • ACMR N/A
  • EPS Growth
  • SUPN 6500.00
  • ACMR 31.52
  • EPS
  • SUPN 1.32
  • ACMR 1.53
  • Revenue
  • SUPN $661,817,000.00
  • ACMR $782,118,000.00
  • Revenue This Year
  • SUPN N/A
  • ACMR $20.20
  • Revenue Next Year
  • SUPN $9.32
  • ACMR $15.63
  • P/E Ratio
  • SUPN $23.30
  • ACMR $12.65
  • Revenue Growth
  • SUPN 8.94
  • ACMR 40.23
  • 52 Week Low
  • SUPN $25.53
  • ACMR $13.87
  • 52 Week High
  • SUPN $40.28
  • ACMR $30.64
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 40.39
  • ACMR 37.93
  • Support Level
  • SUPN $29.77
  • ACMR $18.04
  • Resistance Level
  • SUPN $34.26
  • ACMR $20.86
  • Average True Range (ATR)
  • SUPN 1.51
  • ACMR 1.62
  • MACD
  • SUPN -0.04
  • ACMR -0.28
  • Stochastic Oscillator
  • SUPN 22.05
  • ACMR 35.23

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About ACMR ACM Research Inc.

ACM Research Inc is a United-based company. It is engaged in developing, manufacturing, and selling single-wafer wet cleaning equipment, which is used by semiconductor manufacturers in numerous manufacturing steps to remove particles, contaminants, and other random defects to improve product yield, in fabricating integrated circuits, or chips. The company offers space alternated phase shift which employs alternating phases of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces on a microscopic level; and Timely Energized Bubble Oscillation technology which provides effective, damage-free cleaning for both conventional two and three-dimensional patterned wafers at process nodes.

Share on Social Networks: